Delivery Order SPE2DB20D2002-SPE2DB25FL30G
Award Date
3/26/25
Potential Completion Date
3/27/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,803.10 firm fixed-price delivery order is for the supply of Provocholine Inhalation Solution Packs, a medical product used in various healthcare applications. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,136.52 firm fixed-price contract is for the supply of 4565334260 - Provocholine Inhalation Solution Packs (18mL). The contract has an ultimate completion date of August 5, 2024 and was awarded on August 2, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of a pharmaceutical product, Provocholine Inhalation Solution, valued at $1,173.82. The contract has a firm fixed price and an ultimate completion date of September 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide this critical medical product to support the healthcare needs of military treatment...
This federal contract award, valued at $1,650.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Provocholine inhalation solution, a medical product used in healthcare settings. The contract has an ultimate completion date of March 28, 2025 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award, valued at $2,750.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, is for the supply of Provocholine Inhalation Solution (4567732994) with a completion date of March 31, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,472.08 firm fixed-price delivery order is for the supply of Provocholine inhalation solution, with a period of performance ending on September 4, 2024. This award is not associated with a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous contracts by various defense and civilian...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Provocholine inhalation solution. The $9,795.60 firm-fixed-price contract has a September 2023 completion date and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award is for the delivery of Provocholine Inhalation Solution, a medical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and is valued at $1,068.26. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,268.83 firm fixed-price delivery order contract is for the provision of Provocholine 100 mg vials, a medical product used in healthcare. The contract has a period of performance through February 9, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,572.10 firm-fixed-price contract is for the supply of Provocholine 100 mg vials, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for the provision of a comprehensive range of...